4t Score Calculator

Heparin-induced thrombocytopenia is an antibody-mediated reaction in which IgG binds complexes of platelet factor 4 and heparin, and the resulting immune complexes cross-link platelet Fc gamma RIIa receptors. The platelets are activated rather than merely destroyed, which is why the syndrome causes clotting at the same time as the count falls, with thrombosis in up to half of untreated cases and a venous predominance. The 4T score exists because confirmatory assays take hours to days while the decision to stop heparin has to be made immediately. Each of thrombocytopenia, timing, thrombosis, and other causes scores 0 to 2, for a total of 0 to 8, with 0 to 3 low probability, 4 to 5 intermediate, and 6 to 8 high. The scoring rules encode the biology rather than being arbitrary. A fall of more than 50 percent with a nadir at or above 20,000 per microlitre scores highest because a profoundly low nadir, under 10,000, argues instead for immune thrombocytopenia, disseminated intravascular coagulation, or marrow failure; HIT rarely drives the count that far down. Timing rewards a fall on days 5 to 10, the interval required to mount a primary IgG response, or within one day if heparin was given in the preceding 30 days and antibodies persist. The score performs best in the negative direction: pooled validation studies report a negative predictive value above 98 percent for low scores, so it reliably excludes the diagnosis, but positive predictive value at intermediate scores is poor and demands laboratory confirmation. Interobserver agreement is only moderate, and the score performs less well in intensive care, where competing causes of thrombocytopenia are ubiquitous.

Thrombosis appearing paradoxically in patients receiving heparin was reported by surgeons in the late 1950s, and in 1973 Rhodes, Dixon, and Silver demonstrated an antibody basis by showing that patient plasma aggregated donor platelets in the presence of heparin. The target antigen was identified two decades later, when work in the early 1990s established that the antibodies recognise a conformational epitope on platelet factor 4 only when it is complexed with heparin, explaining why the reaction depends on the ratio of the two and why larger unfractionated chains are more immunogenic than low-molecular-weight preparations. Functional testing advanced in parallel with the serotonin release assay described by Sheridan, Carter, and Kelton at McMaster University in 1986, which remains a reference method. The 4T scoring system was developed by Theodore Warkentin, also at McMaster, during the late 1990s as a structured pretest probability tool for the period before assay results return, and it was formally evaluated by Lo, Juhl, Warkentin and colleagues in the Journal of Thrombosis and Haemostasis in 2006 against a large cohort with functional assay confirmation. A systematic review and meta-analysis by Adam Cuker and coauthors published in Blood in 2012 pooled thousands of patients and established the very high negative predictive value that underpins current practice. The American Society of Hematology guidelines issued in 2018 formally recommend calculating the score before ordering an immunoassay, and reserve confirmatory functional testing for intermediate and high scores.